# Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)

> **NCT00610441** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 67 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** MK-8777
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00610441
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-01
- **Primary completion:** 2009-03-02
- **Final completion:** 2009-03-09
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2018-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00610441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00610441, "Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00610441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*